drugset
drugset / Trial / NCT04667507

Pharmacokinetics of Aqueous Dexamethasone

NCT04667507 ↗

Phase 4 Completed 102 enrolled Frank A. Bucci, Jr., M.D.
RandomizedParallel-groupOpen-labelTreatment

Summary

The study is being done to measure the absorption of the DEXTENZA implant and inflammation concentration levels in the eye.

Timeline

Start
2021-01-01
Primary completion
2021-10-31
Completion
2022-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.4 mg Other

Indications

No indication recorded.